Padma Bhushan Dr. Nandkishore Shamrao Laud to receive Lifetime Achievement Award at India Leadership Conclave 2013
The Veteran & Noted Orthopedic Surgeon Selected for social commitment, Outstanding Innovation in Medical Practice & Setting New Trends in hip-and-knee replacement surgeries.
Tuesday,21st May 2013, Mumbai, Maharashtra, India : Noted & eminent Orthopedic Surgeon Dr. Nandkishore Shamrao Laud who was conferred Padma Bhushan for his contributions in the field of medicine will be receiving the prestigious Lifetime Achievement Award at Asia’s Biggest Leadership Event, the 4th Annual India Leadership Conclve & Indian Affairs Business Leadership Awards 2013 ( www.indialeadershipconclave.net/2013 ) organised by Asia’s widely acclaimed News Media Indian Affairs ( www.indianaffairs.tv ) on Friday,21st June at Hotel Lalit, Mumbai, India at a power packed congregation of top 300 leaders of the country who will assemble to discuss the roadmap of India in the changing political, business & social environment under the theme, “New India, Agenda For Change”. The Conclave will witness sixty top leaders debating on the latest dynamics of change post free independent India.
Organised by Indian Affairs, the 4th Edition of India Leadership Conclave & Indian Affairs Business Leadership Awards will recognize & honour iconic figures in Juries non voting special category including business magnet Ratan Tata, Mukesh Ambani, Actress Priyanka Chopra, Fashion Designer Manish Malhotra, Eminent Healthcare Economist Dr Mukesh Hariawala,Padma Shri Dr Mukesh Batra & others. Dr. Nandkishore Shamrao Laud popularly known as Dr Nandu Laud will be conferred the coveted & prestigious Lifetime Achievement Award for Dr laud’s pioneering innovations in Medicine, including the much talked about specialization in hip-and-knee replacement surgeries which has won many national and international honours Said Satya Brahma, Chairman & Editor-In-Chief while announcing the coveted Lifetime Achievement Award honour. “Dr Laud has set an examples for others who are pursuing medicines specially in Orthopedics to know more about hic critical cases of administration & has brought glory to India from overseas medical fraternity. Dr Laud is a trend-setter & an excellent philanthropist besides a successful surgeon” said Satya in a release to Media.
In a letter addressed to Mr Satya Brahma, Chairman, Organising Committee of 4th Annual India Leadership Conclave & Indian Affairs Business Leadership Awards, Dr Laud said, Dr Laud Clinic sincerely thank you for your gracious recognition which I certainly appreciate & feel honoured to have been conferred the "Life Time Achievement Award" for my contribution in healthcare. Besides Joint Replacement Dr Laud pointed out that for the last 45 years, Dr Laud have been involved in a unique experiment in running a Citizen's co-op hospital which is owned by 19,000 citizens - a unique concept to offer cost effective healthcare at an affordable rate by self participation. Since Dr Laud firmly believe that the cost in healthcare is rising and equally the responsibility of families and if they contribute and make provision, it would be possible to offer a good healthcare package at a very reasonable cost.Our experiment at Shushrusha Citizen's Co-op hospital, amply proves that. Dr Laud Clinic are now in the process of building another Citizen's hospital in Vikhroli, Dr Laud added.
Dr Laud is the Ex-Professor and Head, Department of Orthopaedic Surgery and Traumatolgy and Chief Trauma Service, L.T.M.Medical College and L.T.M.G.Hospital, Sion, Mumbai & Chairman and Consultant Orth. Surgeon, Shushrusha Citizen's Co-operative Hospital, Ltd. Dadar, Mumbai, Chairman Board of Studies - Faculty of Surgeries, University of Bombay, Consultant Orthopaedic Surgeon, Breach Candy Hospital & Research Centre, Mumbai,Consultant Orthopaedic Surgeon - Laud Clinic. Dr Laud has been Inspector for inspection of various hospitals for recognition as Post Graduate Training in .S.Orthopedics and D.N.B. by Medical Council of India and National Board of Examinations, New Delhi, 1980 - 1995
Post Graduate teacher and examiner at D.Orth and M.S. Ortho. Examinations at University of Mumbai, Shivaji University, Kolhapur, Marathwada University, Gujart University, Delhi University. Post Graduate Institute of Medical Educational and Research, Chandigarh, All India Institute of Medical Sciences, New Delhi and many others 1977-1998. Dr laud has been in International Membership Education foundations , Trustee, AO/ASIF International Foundation, Davos, Switzerland, since 1992-2002 & Member, Advisory Committee, Association of Trauma Care of India,Council Member, Asian Association for Dynamic Osteosynthesis, Hong Kong.Founder Member, Indo German Orthopaedic Foundation,Secretary, Ranawat Orthopaedic Research Foundation, New York, USA.Chairman, Indian Section. Dr Laud held Positions at the National & International Organisations & has been Past President & Past Secretary & Secretary General at Co-ordination Committee of Honorary Medical Officers of Municipal Medical Institutions in Greater Bombay. Dr Laud was the President of the Indian Society of surgery of hand, Bombay Orthopaedic Society, Senior Medical Teacher's Association, L.T.M.G. Hospital Mumbai, Indian Orthopaedic Association 1996-97, 1997-98,Vice President: Indian Arthoplasty Association & Group Leader For Rehabilitation Work in Natural disaster at Bihar famine work in 197 and Kilari, Lather in 1993. Dr Laud’s Expert Assignments incude an honor of being appointed as an expert on the committee by the Governor of Haryana to develop the Pandit B.D. Sharma Post Graduate Institute of Medical Sciences, Rohtak into an Institute of Excellence for Trauma care and superspeciality and attended various meetings in Delhi.Expert on the Committee appointed by Chairman Human Rights Commission, Shri Justice Anand to propose Emergency Medical and Trauma Services Plan,Co-inventor and contributor in clinical research and development of an indigenous elastic fixator device for management of Complex Trauma, birth defects and neglected injuries in Orthopaedic practice. A Minimal Access Technique - Hold a patent for the same. Dr Laud has Published many scientific papers based on original research work in national and international journals.
The Lifetime Achievement Award to Dr. Nandkishore Shamrao Laud will be conferred on Friday, 21st June 2013 in Mumbai.
Infinite Computers Enters The Elite List of Respected Software Companies, To Receive Coveted “India’s Most Respected Company in Corporate Governance & Excellence Award” at 4th Annual India Leadership Conclave & Indian Affairs Business Leadership Awards 2013
Infinite Computers Selected For Corporate Governance Awards By an Eminent Juries For Sustained Investors Confidence, Corporate Excellence, HR Practice
Mumbai, Maharashtra, India, Friday,17th May 2013 : Leading IT and mobility solutions provider Infinite Computer Solutions BSE Code (533154), a vertically integrated software MNC & a leading global service provider of application management, infrastructure management, product engineering, services, as well as mobility and messaging solutions in the telecom, healthcare, media and content, energy and utilities and banking, financial services and insurance (BFSI) is set to receive the coveted & prestigious “India’s Most Respected Company in Corporate Governance & Excellence Award” at 4th Annual India Leadership Conclave & Indian Affairs Business Leadership Awards 2013 ( www.indialeadershipconclave.net/2013 ) in June 21st in Mumbai organized by illustrious media house Indian Affairs (www.indianaffairs.tv ), a division of Network 7 Media Group based in US. India Leadership Conclave is hosting its 4th edition of annual affair under the theme New India – Agenda for Change.
India Leadership Conclave & Indian Affairs Business Leadership Awards are the set of credible & prestigious awards conferred to organizations & individuals after a credible nomination process & multi layer methodology to determine the companies for their outstanding & remarkable presence in their respective fields. Judged by a team of noted & industry experts, The Award recognizes the achievements and excellence in management acumen, financial performance, corporate social responsibility, environmental practices and investor relations with high standards set and uphold by Corporate Governance These honours are designed to inspire excellence among the different layers in corporate hierarchy, especially now that India continues to gain further recognition in the global arena as a favoured investment destination in view of its robust economic growth. Committed to the highest standards of disclosure, transparency and fairness in disseminating information. Apart from the regular periodic reports submitted to the regulatory authorities, In today’s business environment, investor relations play a crucial in corporate existence as they are instrumental in providing timely updates of the latest information and business development to keep the shareholders informed.
Announcing the name of Infinite Computers in special Jury category for “India’s Most Respected Company in Corporate Governance & Excellence Award”, Satya Brahma, Chairman & Editor-In-Chief of Indian Affairs said, “In today’s business environment, information is key & a sound corporate entity & These accolades are for people who possess strong leadership in guiding the board of directors and the company management in growing/expanding the business, and at the same time uphold the highest ethics in business practices. These recognitions are a fundamental part of our mission to enhance the standards of corporate governance”. Infinite Computers has excelled in corporate governance & a clear Leadership in Corporation sustainability. The honour is bestowed as it is recognized by their peers, investors, academics for their outstanding leadership and contributions in a public listed company. Infinite Computers, has helped in steering a company through a period of extraordinary growth, even amid a backdrop of a financial/economic crisis or other major market developments. In the process, it has significantly protected or even enhanced shareholder value as it guided the company in pursuing the business opportunities, thus improving shareholder returns said Satya in a news release.In the past, The Awards were given to the IT Majors Infosys, Mindtree, TCS in the last three successive annual meets.
Leading IT and mobility solutions provider Infinite Computer Solutions had a modest beginning in the year 1999 September & During the year 2005-2006, the company acquired Hyderabad based Datagrid Services to diversify & fuel the business into new revenue segment with an intent to de-risk the business model. The Company was renamed as Infinite BPO Private Limited.During the year 2007-2008, Infinite Computer Solutions Inc, USA the wholly owned subsidiary acquired Comnet International Co. USA, a telecommunication focused product development Company based in Chicago, USA through a 100% Stock Purchase. The company has three main service offerings - Infrastructure Management, Intellectual Property (IP) leveraged solutions and IT services focused on the Telecom and Media, Technology, Manufacturing, and Healthcare industry.
Infinite Computers has thus entered the list of illustrious fortune 300 companies at India Leadership Conclave & Indian Affairs Business Leadership Awards platform where more than 300 top business houses has been recognized & honored. Speaking on the announcement Upinder Zutshi, CEO & MD, Infinite Computers said “ It indeed is a rare honour & reflect our commitment to the corporate governance & fair corporate practice, Infinite is currently experiencing an exciting phase of its tenure where IPR & core competence in Telecom, Healthcare, Energy & Utilities, Media & Content and Banking & Finance industries to provide Application Management, Infrastructure Management and Product Engineering Services including Mobility & Messaging Products and Solutions.
Telecom focused Indian IT vendors that have built proven capability, by working closely with large carriers across various segments of the telecom carrier value chain are likely to have the right industry insight. They are now strategically positioned to ride the next wave of growth in IT services within the telecom domain. The comfort level of the clients has the potential of spawning a new era in relationship extension as clients would agree to offshore critical applications. This could help the customers reduce the total cost of ownership for these applications and cut the time to market enhancements or new roll outs. Both carrier and OEM focused engagements will likely be key beneficiaries and hence any Indian IT vendor that spans across both the domains is uniquely positioned to benefit across the entire value chain & In the past, most of the fortune 500 customers would limit their set of choices for off shoring to just top few names in the Indian IT space. This phenomenon is now undergoing a transition as some of the customers are now seeking alternate vendors than restricting themselves to a select few. We believe that - 50 -some of the fortune 500 customers now feel that they might get higher attention and hence more value for money for their large to midsized engagements with an alternate mid-sized vendor than with one of the large ones. The other driver for this shift is that some of the non fortune 500 customers themselves are wary of approaching the large vendors for they might not get the desired attention. For growing midsized organizations that have the right size and established pedigree, the above trend provides enormous opportunity to expand and demonstrate our value proposition to customers said Upinder Zutshi to Indian Affairs.
The Award will be presented in a glittering award ceremony with top 300 iconic leaders across the globe at a suburban hotel in Mumbai on 21st June 2013.
Global Hospitals, Apollo, Fortis, Columbia & Max Healthcare in race for India’s Most Valuable Healthcare Chain Award at ILC 2013
With Healthcare Expenditure on Rise, FDI, Top 5 Hospital Giants, Global Hospitals Group,Apollo Hospitals Group,Fortis Hospitals Group,Columbia Asia Hospitals& Max Healthcare compete for Top Recognition
Mumbai, Maharashtra, India, Wednesday, 15th May 2013: Asia’s biggest leadership platform at 4th Annual India Leadership Conclave & Indian Affairs Business Leadership Awards 2013 is getting bigger & bigger with key players in the healthcare chain are running neck to neck for the top recognition, India’s Most Valuable Healthcare Chain at ILC 2013. In the nomination are country’s top 5 admired & respected Hospital Chain Global Hospitals Group,Apollo Hospitals Group,Fortis Hospitals Group,Columbia Asia Hospitals,Max Healthcare are in public voting. India is one of the world’s most lucrative healthcare markets, and is expanding rapidly. The Indian healthcare industry is seen to be growing at a much rapid pace than it was anticipated before and is expected to become a $238.76 billion industry by 2020. A number of major players in the healthcare sector are actively participating in the growth through expansion plans and putting in huge investments in the sector. According to the Investment Commission of India, the healthcare industry in India has experienced remarkable evolution of an added 12 percent per year during the last 4 years driven by a number of factors such as increase in the average life expectancy and average income levels, and rising awareness for health insurance among consumers.
“While India is emerging out to be the major destination for Medical tourism & given the current flow of investments made by the leading Hospitals, Global Hospitals Group,Apollo Hospitals Group,Fortis Hospitals Group,Columbia Asia Hospitals& Max Healthcare are definitely increasing their boundaries, investments, global drives & creating large pool of talents, At least in this sector, Indian Doctors are optimist of their career & not looking at overseas lucrative assignments” said Satya Brahma, Editor-in-Chief of Network 7 Media Group in a release. Friday 21st June will only tell the big answer on who will don the mantle of India’s Most Valuable Hospital Chain. 4th Annual India Leadership Conclave & Indian Affairs Business Leadership Awards 2013 ( www.indialeadershipconclave.net/2013 will be hosted by Indian Affairs ( www.indianaffairs.tv )in Mumbai on 21st June under the theme New India – Agenda For Change with the leading voices of india deliberating on crucial issues.
Global Hospitals Private Ltd. provides specialty care and multi organ transplantation services in India. The company provides its transplantation services for liver, heart, lung, kidney, and bone marrow. It also offers medical and surgical gastroenterology, minimal access surgery, cardiology and cardiothoracic surgery, liver treatment, nephrology and urology, orthopedics and joint replacement, internal medicine and critical care, pediatrics, gynecology, ENT, radiology, imaging, and anesthesia services, as well as laparoscopic training and DNB services. In addition, the company provides laboratory services in the areas of ultrasound, X-ray, bone densitometry, colonoscopy, CT scan, Doppler, echocardiogram, endoscopy, holter monitoring, mammography, MRI scan, sigmoidscopy, and spirometry. Further, it operates a nursing school. The company was incorporated in 1998 and is based in Hyderabad, India. It has additional locations in Hyderabad, Bengaluru, and Chennai, India.
Fortis Healthcare Limited owns, operates, and manages multi-specialty hospitals. Its healthcare facilities offer a range of specialty medical services, such as cardiac care, orthopaedics, neurosciences, metabolic diseases, renal care, oncology, and mother and child care, as well as other services, such as cosmetic surgery, ophthalmology, pulmonology, ear nose throat care, and dermatology. As of April 25, 2013, it operated a network of 76 hospitals, approximately 12,000 beds, approximately 600 primary care centers, 191 day care specialty centers, and approximately 230 diagnostic centers in the Asia Pacific region, including India, Hong Kong, Singapore, Australia, New Zealand, Canada, Dubai, Sri Lanka, Mauritius, Nepal, and Vietnam. Fortis Healthcare Limited was formerly known as Fortis Healthcare (India) Limited and changed its name to Fortis Healthcare Limited in March 2012. The company was incorporated in 1996 and is based in New Delhi, India. Fortis Healthcare Limited is a subsidiary of Fortis Healthcare Holdings Private Limited.
Apollo Hospitals Enterprise Limited provides healthcare services primarily in India, Mauritius, Bangladesh, and Kuwait. The company’s healthcare facilities offer treatment for acute and chronic diseases in primary, secondary, and tertiary care sectors. Its tertiary care hospitals provide care in approximately 50 specialties, including cardiac sciences, oncology, radiology and imaging, gastroenterology, neurosciences, orthopedics, and critical care services, as well as specialize in minimally invasive surgeries and transplantation. In addition, the company offers pre-commissioning consultancy services, such as feasibility studies, infrastructure planning and design advisory services, human resource planning, and recruitment and training services, as well as medical equipment planning, sourcing, and installation services; and post-commissioning consultancy services consisting of management contracts, franchising, and technical consultation. Further, it licenses the Apollo brand name for use by the radiology and laboratory services department of a hospital in Kuwait; and operates stand-alone pharmacies that provide medicines, hospital consumables, surgical and health products, and general over-the-counter products. Additionally, the company provides end-to-end medical outsourcing services, consisting of revenue cycle management of clients-hospitals; and professional services, including medical coding, billing and records maintenance services, and patient claims management services to doctor groups, hospitals, and insurers in the United States. It also offers telemedicine services, education and training programs, and research services. As of January 21, 2013, the company owned 8,500 beds in 50 hospitals, 1,350 pharmacies, 100 primary care and diagnostic clinics, and 100 telemedicine units in 9 countries. Apollo Hospitals Enterprise Limited was founded in 1979 and is based in Chennai, India.
Max Healthcare Institute Limited operates healthcare facilities with indoor and outdoor patient care in India. The company offers healthcare services through its 9 facilities in Delhi and the National Capital Region, and 2 facilities in Mohali and Bathinda. It provides services in the areas of cardiology, orthopedics and joint replacement, cancer, neurosciences, pediatrics, obstetrics and gynecology, aesthetics and reconstructive plastic surgery, internal medicine, eye and dental care, endocrinology, diabetes, obesity, ENT, metal health and behavioral sciences, physiotherapy and rehabilitation, and nuclear medicine, as well as minimal access, metabolic, and bariatric surgery. The company is based in New Delhi, India. Max Healthcare Institute Limited is subsidiary of Max India Limited.
Columbia Asia is an international healthcare group operating a chain of modern hospitals across India, Malaysia, Vietnam and Indonesia. The company’s highly skilled medical experts deliver care in hospitals specifically designed for the needs of patients and built for maximum comfort and efficiency. Columbia Asia Hospitals Pvt. Ltd.is one of the first healthcare companies to enter India through 100% foreign direct investment (FDI) route.Columbia Asia hospitals are clean, efficient, affordable and accessible. The innovative design of the hospitals, from their manageable size to their advanced technology, is focused on creating positive experience for patients.
Award Winning Healthcare Economist Dr Mukesh Hariawala will deliver a Keynote Lecture on the changing Business Outlook Post Barack Obama’ 2nd Term
Mumbai, Maharashtra, India, Monday, 13th May 2013: Noted Healthcare Economist & Award Winning Indian American Surgeon Dr Mukesh Hariawala will deliver an important Keynote Address at the 4th Annual India Leadership Conclave & Indian Affairs Business Leadership Awards 2013 ( www.indialeadershipconclave.net/2013 organised by Asia’s most analytical news media Indian Affairs ( www.indianaffairs.tv ) in association with the Ministry of Corporate Affairs, Govern ment of India at a power packed industry gatherings on Friday,21st June 2013 in a suburban hotel in mumbai,india. Network 7 Media Group is organizing its historic 4th Edition of India Leadership Conclave 2013 with top leading faces of india addressing at the conclave under the theme “New India, Agenda For Change”. More than 300 business tycoons, diplomats, politicians,social reformers & delegates from middle east, Europe are expected to attend the high profile set to throw a new directions to the new india.
Dr Mukesh Hariawala will specially fly from Boston, US, to India to deliver the Keynote Address on " Barack Obama’ 2nd Term, Business Implications on Indian Healthcare System”. With the president's re-election, "Obamacare" moveing forward, President Obama's health plan, the Affordable Care Act (ACA), includes provisions that require upgrades to health care IT; many health systems already have begun the process of converting to electronic medical records. The ACA also has provisions that directly affect consumers, such as allowing everybody to apply for health insurance electronically. The changes also encourage more electronic communication and coaching between providers and patients, such as video chats instead of office visits. In general, Americans can expect a continuation of Obama's first-term technology policies. Look for more battles over how much control telecommunications companies have over the Internet, and for efforts to shore up cyberdefenses and increase access to broadband. There are mixed responses in india on what Indian Healthcare system is going to gain out of the Obamacare, Experts feel that Dr Mukesh Hariawala’s lecture will throw new lights & open up wider debate considering Hariawala’s close understanding of Indo-American business implications.In a statement to Indian Media, Hariawala has stressed Medical Tourism revenues , increased IT contracts, generic drug company revenues, overseas insurance company investments in Indian healthcare facilitated by friendly retail FDI policies, all cumulatively would accelerate the GDP trajectory from a limping 5% to the earlier projected 8% rate. This undoubtedly will help increased multi sector employment and improve living standards for a good portion of the Indian population ".
Speaking on Dr Hariawala’ acceptance of Invitation to address the strong intellectual gatherings, Satya Brahma, Chairman & Editor-In-Chief of Pharmaleaders ( www.pharmaleaders.tv ) “ While Indian Inc has welcomed President Obama’s 2nd term as a good news for india, there are many who are doubtful of Obamacare policy & the business implications in india considering Obama’s disastrous first tenure which remained in words & did not significantly change the indo-Us business environment. While President Obama is struggling hard to keep everybody happy specially the Healthcare Insurance Policy, Dr Mukesh Hariawala’s Keynote is expected to dispel the myths & misunderstandings & bring cheers to Indian inc with a wide array of reforms & policy formulations in coming days, said Satya in a release.
India is best positioned to take advantage with its extensive network of highly qualified well trained doctors supported by an infrastructure of world class corporate hospitals offering the same services as the US, at 20% of all inclusive costs for most procedures . This according to Florida based MTA ( Medical Tourism Association ) could bring in billions of dollars of revenue giving birth to a highly competitive parallel healthcare industry. " Obamacare " will also necessitate revamping of all the computing systems handling healthcare which would open a wide door of business opportunity for Indian IT companies. Purely for financial reasons, this will in all likelihood compel the US government to continue large outsourcing contracts. The key economic driver of Obamacare vision is to reduce the trillion dollar healthcare burden on the exchequer. One method likely to be employed is government supported encouragement in larger usage of generic medicines for the US population. This major paradigm shift could benefit the competitively priced Indian generic drug manufacturers who could dominate the supply chain, said Dr Hariawala.
Dr Mukesh Hariawala is a Harvard trained Indian American Cardiac Surgeon with a unique qualification of an Healthcare Economist. In 2009, he was one of the 1st heart surgeons in the world to graduate with an accredited MBA from a premier US University. This has been followed by his appointment as " Adjunct Visiting Professor " at several global business schools with his teaching specialization on " Dynamic Changes in International Healthcare Marketplace ".Additionally, he has consistently demonstrated visionary concepts of improving Indian Healthcare encouraging induction of " Womb to Tomb " Insurance models, Acceleration of generic drug exports, Fast track protocols for the $100 Billion Medical Tourism business opportunity and Institution of creative levers to strengthen Indo - US collaborations during and beyond President Barack Obama's second term in office.Dr Hariawala has won several scientific accolades worldwide for his seminal work on Angiogenesis & Stem Cells. He now has the rare distinction amongst NRI doctors to hold appointment as “Visiting Honorary Cardiac Surgeon & Director of International Programs " at Mumbai's prestigious Jaslok Hospital.
Upinder Zutshi Of Infinite Computers & Ranbaxy CEO Arun Sawhney in close Race for CEO of the Year Award 2013
4th Annual India Leadership Conclave & Business Leadership Awards 2013 CEO of The Year Nominees in Close Competition as 5 Nominees Receive Overseas Votes
Mumbai, Maharashtra, India, Thursday, 9th May 2013: With the judgment date nearing to 42 days more, the 4th Edition of India Leadership Conclave & Indian Affairs Business Leadership Awards 2013 organized by Asia’s biggest analytical News Magazine Indian Affairs ( www.indianaffairs.tv ) in collaboration with the major trade bodies, Government & Associations, The CEO of the Year Award has received great response from 5 million voters consisting of 7 continents & 8 States with the CEO’s participating the votings. While as per trends available now, Upinder Zutshi Of Infinite Computers & Ranbaxy CEO Arun Sawhney in close Race for CEO of the Year 2013 are in close race while Puneet Chadda, CEO, HSBC Asset Management, Jayant Dua. MD & CEO, Birla Sun Life Insurance & Ishan Raina. CEO & Managing Director, Out of Home Media (India) are eyeing for the top recognition. It may be recalled here that last year Mohit Anand of Belkin India & Dr Kannan Vishwanathan were the favourites. The 4th Edition of India Leadership Conclave & Indian Affairs Business Leadership Awards will be held in Mumbai, India on 21st June 2013 at Hotel lalit with the theme New India – Agenda For Change.
In a release to the Media, satya Brahma, Chairman of the Organizing Committee of the 4th Annual India Leadership Conclave & Indian Affairs business Leadership Awards 2013 ( www.indialeadershipconclave.net/2013 ) said ‘’ New India & Indian Inc are experiencing a great deal of competition from their contemporary peers & pressure to perform better & live to the growing expectations from the internal & external stakeholders, with staggering Indian economy resulting in lack of economic reforms due to erosion of political values in the corridors of power at the centre, it is the top leadership which play a critical role in policy formulation & vision of the Company, the stakes are too high as both Indian & overseas market are posing biggest challenges. Given such a situation, CEO of The Year Award 2013 has drawn the attention in public perception & all the five nominees are the most credible & visible faces of the New India said Satya Brahma. The Nominees are Puneet Chadda, CEO, HSBC Asset Management (India) Pvt Ltd. (Code 31),Jayant Dua. MD & CEO, Birla Sun Life Insurance. (Code 32),Mr. Arun Sawhney. CEO & Managing Director, Ranbaxy Ltd. (Code 33),Mr.Upinder Zutshi. MD & CEO, Infinite Computer Solutions India Ltd. (Code 34),Mr.Ishan Raina. CEO & Managing Director, Out of Home Media (India) Pvt. Ltd. (Code 35).
Puneet Chaddha, Chief Executive Officer,HSBC Asset Management (India) Private Ltd. Puneet Chaddha is the CEO for HSBC’s Asset Management business in India with responsibility for overall management of the business including driving business development and strategy. He also sits on the Asia Pacific Executive Committee which steers HSBC’s funds business in the region.Puneet has nearly 21 years of experience in the financial services sector spanning a variety of disciplines such as Currency Trading and Advisory, Consumer Lending, Capital Markets and Corporate Banking. He has been with the HSBC Group for about 18 years. Prior to his current role, Puneet headed HSBC’s Commercial Banking business.An engineer back background, Puneet also holds a management degree. He has also completed several executive development programs from prestigious institutes such as INSEAD and Harvard Business School.
Jayant Dua is the Managing Director and Chief Executive Officer at Birla Sun Life Insurance. He is a Chemical Engineer from IIT Delhi and an MBA. He also holds an Advanced Management Program (AMP) from Harvard Business School, USA. He joined Birla Sun Life Insurance in July 2010.In his role, he provides Birla Sun Life Insurance a strategic direction and leads the insurance team towards achieving rapid growth and profitability.Prior to this, Jayant spearheaded Aditya Birla Insulators (ABI) in the capacity of President and CEO and was responsible for expanding ABI’s customer base nationally and internationally. He was instrumental in making the ABI business the fourth largest in its segment globally. He has been associated with the group for the last 16 years and prior to his appointment with the Insulators Business, Jayant spent close to a decade in Groups’ Cement Business in capacities as diverse as Marketing, IT and Strategy.
Mr. Arun Sawhney, B.Com., PGDBM has been Managing Director at Ranbaxy Laboratories Ltd. since August 20, 2010 and serves as its Chief Executive Officer. Mr. Sawhney is an industry veteran with over three decades of international experience in the Chemical and Pharmaceutical sectors. He served as President of Global Pharmaceuticals Business at Ranbaxy Laboratories Ltd. and served as its President of API GBU- Global Manufacturing & Supply Chain. Mr. Sawhney served as the President of Bulk SBU and Member of Management Council of Dr. Reddy's Laboratories Ltd. Mr. Sawhney started his tenure at Dr. Reddy's in 2001, and served as its President - Europe and Global of API business until May 5, 2008. Prior to Dr. Reddy's Laboratories's he served as Chief Executive Officer of Max-GB Ltd. Prior to that, Mr. Sawhney headed the Global Business Development function at Ranbaxy Laboratories Limited. He has also had successful stints as Manager Exports with Hindustan Ciba Geigy and as Regional Sales Manager with Bayer India. Mr. Sawhney has been a Director at Ranbaxy Laboratories Ltd. since August 20, 2010.
Upinder Zutshi as Managing Director and CEO of Infinite is a very unconventional leader, and has nurtured the growth of infinite with a very hands-on-approach. With his remarkable leadership, Upinder has defined the strategic direction of the Company, making Infinite’s revenue grow above industry average. He has been instrumental in setting the vision for Infinite to be positioned as a Global Service Provider and moving the Company up the value chain by focusing on differentiated services and product based offerings in a non-conventional engagement and business models.Under Upinder’s leadership, Infinite has grown to be in the Nasscom Top 20 IT providers in India with a revenue of US$ 220 Million in FY 2012; 5000+ employees worldwide, been named as Top 5 employers in India by Dataquest – IDC, Forbes Asia 200 Best Under a Billion Company in 2012; Top 10 Global Telecom Outsourcing Providers by IAOP and has been recognized as technology thought leaders in the emerging areas like mobility, messaging and analytics. He spearheaded the IPO of Infinite, which was one of the most successful IPOs in 2010, with a historic opening where it was over-subscribed manifold in a stock market where the giants were struggling through a global economic-crisis.
An advertising veteran, Ishan has over 25 years experience in advertising and media. An MBA from Indian Institute of Management, (IIM) Calcutta, Ishan has lent his management expertise to several leading advertising agencies including Lintas and Contract Advertising (a subsidiary of JWT) in India.In 1995, at age 37, Ishan became the Founder-CEO & Joint-venture Partner of Euro RSCG Advertising Worldwide. In 1996, Business India selected him as one of the top 50 influential Indians under 40. From 1998 to 2006, Ishan served as Chairman and CEO of Euro RSCG group in India. He has also served as a board member for Euro RSCG Asia Pacific and a member of the Executive Committee of Euro RSCG Worldwide.Ishan still serves as Chairman of MPG India (Havas Media) and Connecturf, India's online media solutions company.
For more details please view www.indialeadershipconclave.net/2013
Outstanding Contribution to Skincare Innovation Award 2013 Intensifies As Hyderabad Pools More Votes than Delhi & Pune, Dr. Nilayini, Dr. Shuba Dharmana, Dr.Uday Sidhu, Dr.Tripti Rathore, Dr.Rashmi Lohiya at 4th Annual India Leadership Conclave & Awards 2013
Mumbai, Maharashtra, Thursday, 2nd May 2013: 4th Annual India Leadership Conclave & Indian Affairs Business Leadership Awards 2013 has gained momentum with the voting for the all 30 categories received tremendous response from the cross sections of the society. Indian Affairs, A Division of Network 7 Media Group ( www.indianaffairs.tv ) which is hosting the most eagerly awaited Leadership Event in Mumbai under the Theme “New India – Hopes, Aspirations & Changing Outlook 2013. – Agenda for Change –’’ on Friday,21st June 2013 is all set to declare the prestigious Outstanding Contribution to Skincare Innovation Award 2013 with five top Cosmetic Dermatologists selected by the Juries for the top Five Finalists. 1. Dr. Rashmi Soni Lohiya, Head and consultant dermatologist, Cosmetologist.CEO, Dermatologist surgeon, Skinsure Clinic. (Code 21), 2. Dr. Tripti Rathore,Master of Science Dermatology, MBBS,Clinical Director & Lead Dermatologist. ( Code 22).3. Dr. Uday Preet Sidhu. Consultant Dermatologist & Cosmetologist. (Code 23)4. Dr Nilayini. Consultant Dermatologist & Cosmetologist, Founder CEO, Blu skin and cosmetology clinic. (Code 24)5. Dr Shuba Dharmana. Consultant Dermatologist, Hair Transplant Surgeon, Laser Specialist.CEO/Founder Dr.Shuba Skin & Laser Clinic & Le' JEUNE Medspa . (Code 25).
Introductory Brief on Indian Dermatology & Cosmetic Market Space
Indian Challenges with Global Adaptation
With the growing awareness in skin care among people, there is an increasing demand for quality products. Let us take a peek into the cosmeceutical trends expected in the future and the latest innovations in this sector. From the most neglected to the most eyed, Regulatory challenges dermatology & cosmetology is now in focus. Whether it is the therapeutic products or But as marketers strive to present these cosmetics, the new age cosmeceuticals or differentiated offerings for every customer aesthetic treatments, all these categories are need,the regulator is not far behind to demand growing much beyond market growth rates. proof for every functional claim. Substantiating these claims, even for cosmeceutical products,As today's emerging market, India attracts the is thus the need of the hour. Advanced attention of all leading world players in this instrumental techniques to measure various segment. parameters, along with clinical assessment, can now be used to meet this requirement.The Indian dermatology market is growing at Moreover, as India desires to export these more than 20% and represents 25% of the Asia products,international regulations too demand Pacific dermatology market. The cosmetics stringent supporting data.market is estimated to be worth Rs. 20,000 crore by 2014. This seminar thus focuses on all these aspects through an innovative approach that:A vibrant economy,over 50% people under the age of 30, a growing middle class that can spend ¡Will provide...‘in-depth’ and relevant increasingly more,the influence of the glamour sessions from global and local technical industry that makes each one wanting to 'look experts good', are just few of the factors that drive
A hybrid between pharmaceuticals and cosmetics, cosmeceutical are products with biologically active ingredients having drug-like benefits. With changing lifestyle of the people, both men and women are caring about their skin more than ever before. Although women from generations have dedicated time for taking care of their skin, today major women are changing occupation from being just a home maker to being a full-time professional and hence does not have enough time to dedicate to conventional beauty treatments. Thus, the need for fast-acting skin care products aroused. The boom in cosmeceutical coincides with people’s ever increasing interest in natural and safe products. Himani Chandna, Group Product Manager, L’Oréal – Active Cosmetics Division, says, “Cosmeceuticals is a hardcore category of products promising efficacy and are purposive in nature. The inclination of people to use cosmeceuticals comes from the kind of efficacy these products offer.”
The skin care segment will account for 63 per cent of all cosmeceutical product demand through 2012 is expected to grow to $ 22.1 billion in worldwide sales by 2013.
The demand for products for a fair and beautiful skin no more restricts to the females. Even the males today in India are preferring beauty products to take that extra bit of care of themselves. Dr Soma Sarkar, Cosmetologist &Dermatologist & Influencer, Project Effexx – Merck India Initiative, says, “The cosmeceutical market in India is growing by leaps and bounds. The number of patients we attend on a daily basis is testimony to the fact that the demand for pharmaceutical products coupled with cosmetic properties is on the rise.”
The global market was initially focussed on the treatment of acne using retinoid and skin lightening agents such as hydroquinone but with there has been a shift to anti-ageing in the last decade and especially to the ones having natural anti-ageing actives. Chandna further adds, “It will not be a fair to compare the potency of synthetic cosmetics and natural sources. Both undergo years of research in their own way. But in the Indian context, we often see people inclined towards the conventional products from natural sources.”
Dr Sarkar further adds, “Depending on the patient’s requirements, we recommend them products that are often available over the counter to cosmetically treat various skin ailments. These products contain actives with fitting properties that soothe the skin and offer care at the same time. With the increasing demand for these products, the number of pharmaceutical companies producing them has also increased.”
Increasing awareness is the major reason that has caught the attention of Indians to these products. Chandna suggests that it is the involvement of medical practitioners that has made the people aware about such products.
An ageing skin is something that everyone today is fearful about. Everyone wants to look young and beautiful forever. Anti-ageing products are said to drive the market in future. Sarkar explains, “The average age of Indians opting for skin care solutions has changed. Increasingly, people are realising that skin’s ageing process starts at the age of 22 years and it is important to pay attention to it while in its early stages. Anti-ageing is thus one of key drivers in our industry. Apart from this, a lot of patients also come to us for hair care and fine fairness consultation.”
Chandna believes it is the claim of the company and the delivery of the claim in the product that matters the most to the consumer backed with the safety and efficacy of the product.
The consumer is dependent on the medical practitioners and other influencers for the guidance to use the correct product. But at the end it is the consumer’s experience that gets them hooked to the product. Hence, the major reason that a particular product will sustain is the loyalty it shows in delivering the company’s claim.
With the growing awareness the people are opting for products derived from natural resources since they are safer to use as compared to the synthetic ones. Scientists and researchers have discovered the role of dietary components, phytoactives and food ingredients in supporting beauty from within in the form of nuticosmetics and cosmeceuticals for topical applications.
Dr Sarkar suggests, “Addressing your skin care needs by opting for products and services that are derived from natural sources is always a safer option compared to chemically enhanced ones. They are completely bio-degradable and mimic the same chemical components as a regular product.”
Natural antioxidants that quench free radicals are the essential component of the anti ageing formulations. Natural peptides are innovative cosmetic ingredients that can be potentially used to counteract wrinkles formation and loss of elasticity. Dr Sarkar elaborates, “The latest innovations are called ‘nanoceuticals’ that mimic the body’s normal skin protection function. These are essentially nutrients that have been reduced to a nanoscale through a process called nanotechnology. In addition to this, there are specific molecules that have come up for specific ailments.”
Nanoceuticals that were launched around the year 2009 entered every domain the nutrients sector like nutritional supplements, slimming shakes and skin care. There are years of research that goes into the making of these products since there is immense data that needs to be generated before making a claim on the safety or effects of these products. The biggest challenge faced here is the uniqueness of every user and developing the product suiting the needs of maximum skin types as possible.
Forecast for the Indian market
The Indian market has more to expand in terms of cosmeceuticals. The feeling of being beautiful has a psychological impact on the minds of the people that boost a sense confidence among them. The changing definition of being beautiful and external appearance making a big impression are also factors affecting the market. In the Indian culture, for ages there have been conventional innovations to have a healthy beautiful skin. With the rise of cosmeceuticals these conventional methods have been replaced by new fast fix methods. Dr Sarkar adds, “Indians today are conscious about the way they look. With the average disposable income of Indians increasing, they do not restrict themselves from spending on their skin care needs. More often than not, beauty and beautiful skin is a confidence booster for people. It is because of these reasons that more and more people from metros and mini metros in India opt for such solutions. In the years to come, this industry will see a further surge in demand.”Chandna adds, “The industry is growing exponentially and the evolution of the industry will be rapid and the growth is expected between 40-50 per cent.”
With the innovations and new product launches and increasing demand among the people this sector is bound to face a tremendous growth. But to sum it all up its product’s quality that will speak for it and define the success. India is still to explore a lot and a huge market is available for cosmeceutical in the developing countries and the developed ones too.
The methodology used to determine the 2013 Top Indian Innovators Award.
Since 2000, Network 7 Media Group has been presenting the coveted India Leadership Awards to the super performers, game changers & shining stars if Indian Enterprises. Indian Affairs Business Leadership Awards coincide with the Conclave Debate & are presented to the winners after a meticulous judging process, complex votings via SMS, Email, Physical Interaction with the sample size of more than 2 million serious stakeholders of the Indian Society. Indian Affairs Business Leadership Awards 2013 has as many as 30 categories & are most credible, prestigious & precious. Known for its searching perfections in finding the best talent & award the most deserving. Our Panel of Experts have taken every attempt to blend experience with innovations & in no way represent any factor other than professional ethics, innovative approach in treatment & patient’s feedback.
The nomination criteria for Indian Affairs Most Admired Cosmetic Surgeons are considered an industry standard, and are the most important factors for choosing the most qualified surgeons among health professionals. Please keep in mind if a particular surgeon has not been nominated, it does not mean that they are not well qualified. Here is a brief explanation of some our selection criteria: We have determined with the help of our Advisory board of surgeons and doctors that the selection criteria below is the most objective process of evaluating and selecting well-qualified cosmetic surgeons.
Good standing with licensing and medical regulatory authority
Level of specialty training, board certification and education
Level of surgical experience
Professional associations and affiliations
Patient experiences and reviews
Dedication to ongoing education
Integration of technology into practice
Scope of Cosmetic surgical services offered
The coveted Award represents & signifies remarkable contribution of a derma cosmetic surgeon whose track record though not noticed in public glare & media attention, but caught the attention of treatment process & innovative techniques & wider acceptability of Clients or Patients. It is the genuine Endeavour of the Advisory Board of Jury Members to give importance to merit than fame. The Award carries a Trophy, Citation & a Brand Ambassador assignment of a large MNC which will be declared on the Award Night. Widely perceived by the contemporary peers, The Coveted Award is indeed a Lifetime Dream of Any Doctor at India Leadership Conclave Plattform.
The field of skincare innovation is rapidly expanding in India with the demand for better treatment in line with European Standards where the process of treatment involve a great deal of technology & treatment process mechanism said Satya Brahma, Chairman & Editor-in-Chief of Pharmaleaders Group (www.pharmaleaders.tv ). The rise & rise of Indian Middle class with the demand for better treatment in Beauty care has indeed compelled the Dermatologists & Cosmetologists to invest more in research & give the patients a better look, with these aspects having a significant importance, all Five Nominees for the coveted Outstanding Contribution to Skincare Innovation Award 2013 will have big contest said Satya.
Dr Rashmi Soni(Lohiya) is an expert on all matters concerned with skin and hair. With an MBBS from the top ranked BJ Medical College Pune, she then moved to the prestigious KEM Hospital Pune to pursue her MD and Post Graduate Diploma in Dermatology. Her training under the watchful eyes of brilliant professors included every aspect of skin care, skin health, cosmetology and trichology and skin diseases. Since then she has worked with highly reputed skin care chains and with leading hospitals. Her experience led her to believe in the need to set up her own center so she could bring her unique ideals to bear on every client
Dr. Tripti Rathore is the Clinical Director and Lead Dermatologist of Pure TouchSkin. She is a returning dermatologist from England and specializes in cutting edge treatment for skin conditions which includes management of pigment disorders, facial rejuvenation, and chronic skin disorders like eczema, psoriasis, and cancers. She has been working in United Kingdom since 2004. Dr. Rothore has extensive experience working as a Fellow & Registrar at dermatology departments of Southport & Ornskirk NHS Trust, Norfolk & Norwich University Hospitals, Pilgrim Hospital, Boston, and King College Hospital, London. Dr. Rathore has obtained Diploma in Dermatology from Barts & Queen Mary University of London and MSc. Dermatology from University of Hartfordshire, UK. Dr. Rathore received her MBBS from NSCB Medical College, Jabalpur in 2001.
Dr. Uday Preet Sidhu is the consultant dermatologist at Cloudnine Hospitals where she will be seeing Pediatric cases, pregnant women and general and cosmetic dermatology. She has done her MD from Annamalai University, her M.B.B.S from Sri Ramachandra Medical College and Research Institute, Chennai and her fellowship in cosmetic dermatology - Harvard Medical School (USA) Amongst her notable stints she has worked at Kaya Skin Clinic and other well known centres where she has practiced as a dermatologist. Her International exposure has made Dr. Udhay Sidhu to work with Brigham and Women's hospital, Boston and Massachusetts General Hospital, Boston, USA.
Dr Nilayini,Founder,M.B.B.S,DD (Dermatology)(UK), is the prestigious member of American Society of Aesthetic and Cosmetic Physicians. Dr. Nilayini has been accredited nationally and internationally in various advanced cosmetic procedures like Fillers and Botox. She started Blu Skin & Cosmetology – the first of its kind, in the high profile area of Hyderabad ie Jubilee Hills, an abode to many niche clients in and around Hyderabad and from other cities & countries. Blu Skin & Cosmetology is the pioneer among the Beauty Medical Spas in Hyderabad, in terms of facilities , infrastructure & services offered. Blu Skin & Cosmetology was inaugurated by the legendary actor Akkineni Nagarjuna.
A Slimming and Cosmetic doctor in the UK, relocated to Hyderabad, India and working as a Cosmetic Dermatologist and Hair Trnasplant Surgeon at Dr.Shuba Skin & Laser Clinic. We offer the latest advanced technology and treatments in Hair restoration surgery via Strip and FUE, Laser hair removal, Skin Rejuvenation, Anti Aging treatments and other Slimming and Body Contouring treatments.
Dr Shuba was trained in Aesthetic medicine, Dermatology & the Rhythmonutrition foundation course in UK. My work as a GP and as a Slimming doctor at at the National Slimming clinics gives me valuable exerience working with obesity and obesity related health issues. Her Specialties lies in Clinical dermatology, Cosmetic dermatology, Anti-Ageing Skin solutions, Minor Surgical Procedures, Laser Treatments, Hair Transplantation, Skin Consultations, Anti-Ageing skin solutions, Hair Loss Solutions, Scalp Disorders & Skin Rejuvenation treatments like Wrinkle Smoothing Injections with Botulinum, Dermal Fillers, Chemical Peels, Platelet Rich Plasma Therapy, Mesotherapy, Depigmentation Peels, Dermaroller Therapy, Microdermabrasion, Acne Treatments, Laser Hair Removal, Laser Skin Resurfacing, Scar removal, Stem Cell Therapy, Body and facial Contouring etc
With the battle for this coveted Award underway, the final declaration will be made on the 21st June 2013 in Mumbai in a glittering Award Ceremony.
4th Annual India Leadership Conclave & Awards Garners Maximum Votes as Dr. K. Ravindranath of Global Hospitals Group, Rajiv Bajaj of Bajaj Capital & Nirmal Jain of India Infoline, Malvinder Mohan Singh of Fortis Healthcare & Joseph Massey of MCX Stock Exchange Eye For The Top Recognition
Mumbai, Maharashtra, India, Tuesday 30th April 2013: 4th Annual India Leadership Conclave & Indian Affairs Business Leadership Awards 2013 ( www.indialeadershipconclave.net/2013 ) organized by Indian Affairs ( www.indianaffairs.tv ) in association with the Ministry of Corporate Affairs & several leading trade houses is set to declare the top coveted award Business Leader of The Year 2013 as top five business leaders Dr. K. Ravindranath of Global Hospitals Group, Rajiv Bajaj of Bajaj Capital & Nirmal Jain of India Infoline, Malvinder Mohan Singh of Fortis Healthcare & Joseph Massey of MCX Stock Exchange Eye For The Top Recognition. Indian Affairs is hosting this 4th Edition of India Leadership Conclave 2013 after successfully organizing three consecutive years & has garnered much appreciation for its credible Nomination Methodology. The Conclave will have participation from top business tycoons, Social Entrepreneurs, Political Leaders, Diplomats & other leaders. 2013 Theme for the Conclave is “New India – Hopes, Aspirations & Changing Outlook 2013. – Agenda for Change –’’.
Speaking on the Award Nomination of top five Finalists for the Business Leader of The Year Award, satya Brahma, Chairman, Organizing Committee of the Conclave & Editor-In-Chief of Network 7 Media Group said “ 2013 Nomination for the top Title Business Leader of the Year has a great relevance as all five Nominees have made their distinctive mark & has defied all odds under tough situations in their respective fields & have excelled in their growth of their business dynamics, While Dr. K. Ravindranath of Global Hospitals Group & Malvinder Mohan Singh of Fortis Healthcare are biggest finds in Healthcare & Medical Tourism Front, Rajiv Bajaj of Bajaj Capital, Nirmal Jain of India Infoline & Joseph Massey of MCX Stock Exchange are the darlings of the stock market, only the best leader will be chosen based on public votings which are underway nationwide”.
While working in some of UK's top medical institutions, witnessing the hardships of Liver transplant patients and their painstaking ordeal, spending huge amounts of money, Dr. Kancherla Ravindranath realized the urgent need for a Liver transplant facility in India.Deeply touched by the plight of hundreds of patients' and inspired by his late Father's advice to come back to serve India, Dr. Ravindranath relinquished his very successful practice in UK and returned to India to establish Global Hospitals.Dr. Kancherla Ravindranath, is a world-renowned expert in Surgical Gastroenterology, and the founder of Global Hospitals Group – acknowledged as India's fastest growing chain of tertiary care multi super specialty hospitals. Under Dr. Ravindranath's visionary leadership and guidance, Global Hospitals Group has become the premier and niche healthcare center that is in to performing high-end surgeries, such as the first ever liver, heart, twin kidney and bone marrow transplants in Andhra Pradesh and multiple such cutting edge and pioneering surgeries in India. Currently, with eight world class tertiary care Hospitals in Chennai, Bengaluru & Hyderabad, and soon Mumbai centre opening up, today Global Hospitals has grown to be acknowledged as the world's most comprehensive centre for Liver & Pancreas Diseases and Transplantation.
Malvinder Singh have continued to transform his fortune, since selling their pharma inheritance in 2008 for $2 billion. They hived off some assets of Fortis Healthcare, among Asia's largest hospital chains, into Religare Health Trust, which listed in Singapore, raising $417 million. In September, they inked a deal to sell 49% stake in asset management arm of Religare Financial to Invesco for $87 million. Their new venture is Air Mantra, a regional airline connecting cities in North India. Malvinder, a Singapore permanent resident, is executive chairman of Fortis, Shivinder is vice chairman.
Mr. Rajivnayan Rahulkumar Bajaj, Rajiv serves as the Managing Director of Bajaj Capital Ltd. Mr. Bajaj served as Managing Director of Bajaj Holdings & Investment Limited since April 1, 2005. Mr. Bajaj served as Managing Director of Bajaj Holdings & Investment Limited (formerly, Bajaj Auto Ltd.) from March 31, 2005 to February 20, 2008 and its President from March 3, 2002 to February 20, 2008. Mr. Bajaj served as Managing Director of Bajaj Auto Finance Ltd. since April 01, 2005. He served as Joint Managing Director of Bajaj Auto Ltd. from March 12, 2003 to March 31, 2005. Mr. Bajaj joined Bajaj Auto as an Officer-on-Special Duty on December 19, 1990 and served as its Vice President of Products since July 1, 1995. Having obtained extensive on-the-job experience in Bajaj Auto, he has been leading for more than a decade a major technological and marketing reorientation, so as to meet the existing and future competitive challenges. He has been spearheading Bajaj Auto's transition from a predominant scooter and three-wheeler manufacturer to a formidable force to reckon with in the motorcycle segment as well in the areas of product design, development, manufacturing and marketing.
Mr. Nirmal B. Jain, MBA, FHM founded India Infoline Ltd. in 1995 and has been an Executive Chairman since May 7, 2011. Mr. Jain served as Managing Director of India Infoline Ltd. until May 07, 2011. He started his career in 1989 with Hindustan Lever Limited, the Indian arm of Unilever, where he handled a variety of responsibilities, including export and trading in agro-commodities. In 1995, he founded Probity Research and Services Private Limited (later re-christened India Infoline). Mr. Jain subsequently launched www.indiainfoline.com in 1999. He has been Non-Executive Director of India Infoline Finance Limited since July 7, 2004. Mr. Jain was an MBA graduate from Indian Institute of Management, Ahmedabad and holds ACA and AICWA. He holds a Bachelors Degree in Commerce from University of Mumbai. He is a fellow member of the Institute of Chartered Accountants of India and also a cost accountant.
Mr. Joseph Massey, MA, MBA served as the Chief Executive Officer and Managing Director of MCX Stock Exchange Limited since 2009. Mr. Massey served as Managing Director and Chief Executive Officer of Multi Commodity Exchange of India Ltd. since April 2008. He joined Multi Commodity Exchange of India Ltd. (MCX) in May 2003 and served as its Deputy Managing Director from May 8, 2006 to April 2008. He has over 18 years of experience. Mr. Massey served as Managing Director of Life Insurance Corporation, Reserve Bank of India and Stock Holding Corporation of India and also served as Managing Director of ED. He held senior management positions at Vadodara Stock Exchange. He served as the Managing Director of Interconnected Stock Exchange of India. He has been Chairman of Safe since 2010 and also serves as its Director. He serves as a Director of Bahrain Financial Exchange Limited. Mr. Massey has been a Director of MCX Stock Exchange Limited since 2009. He serves as a Non Executive Director of Multi Commodity Exchange of India Ltd., where he previously served as its Director since May 8, 2006. Mr. Massey serves as a Director of National Spot Exchange Limited, Dubai Gold and Commodities Exchange, Safal National Exchange of India Limited., Singapore Mercantile Exchange Pte. Limited., Singapore Mercantile Exchange Clearing Corporation Pte. Limited and FT Knowledge Management Company Limited. He serves as a Non Executive Director of Indian Energy Exchange Limited. He is a regular speaker at financial markets conferences and management institutes.
India Leadership Conclave Nomination in the Business Leader of the Year Category has received maximum voting’s from the cross sections of the society since the voting line opened in April 1st 2013 & will close on 20th June & the Winner will be announced at Affair in the commercial city of India, Mumbai on Friday 21st June in a suburban hotel in a glittering Award Night.
4th Annual India Leadership Conclave & Indian Affairs Business Leadership Award 2013 Nominations Announced
150 Nominees Make It To The 30 Top Categories, Among 7 Special Popular Juries Awards Include Veterans Ratan Tata, Mukesh Ambani, Priyanka Chopra,Manish Malhotra,DrMukesh Hariawala,Dr Mukesh Batra.
Maharashtra, Mumbai, Monday,1st April 2013 : The much awaited & prestigious 4th Annual India Leadership Conclave & Indian Affairs Business Leadership Awards Nominations (www.indialeadershipconclave.net/2013 ) Finalists 2013 are announced today with votings line open organized by Indian Affairs, Asia’s biggest title in News Analysis (www.indianaffairs.tv ) from the illustrious Network 7 Media Group in association with Pharmaleaders, Breakfastnewstv,Pharmanewsprwire. Asia’s premier Event currently in 4th year of its title received as many as 1700 Nominations from various verticals in the Nomination categories will host its 4th Annual Affair in the commercial city of India, Mumbai on Friday 21st June in a suburban hotel under the theme “New India – Hopes, Aspirations & Changing Outlook 2013. – Agenda for Change –’’. The last three editions which received widespread appreciations for its significant debating point were held at Delhi, Mumbai & Bangalore respectively. Widely perceived by the Industry Analysts as a vibrant platform of serious debate, The Conclave will witness more than 300 top business tycoons, Social Reformers, Bureaucrats & Policy makers.
Announcing the Final Nominations, Satya Brahma, Chairman & Editor-In-Chief of Network 7 Media Group said “India Leadership Conclave & Indian Affairs Business Leadership Awards organized by Network7 Media Group’s Indian Affairs Magazine, Asia’s biggest analytical news Magazine, arguably is one of India’s prestigious & coveted title & has established a credible platform of serious discussion where Brand India’s most illustrious Leaders & icons assemble to discuss the roadmap for India’s growth trajectory. The last three Annual Affairs has witnessed some of the biggest think-tanks of the contemporary leaders in society from social to political, from business to cultural, addressed, deliberated & opened up the new mantras of developments. While more than 100 Leaders of Indian mainstream polity have spoken, the platform has recognized & felicitated more than 300 Leaders & Enterprises. Indian Affairs Business Leadership Awards are set of prestigious awards developed by the Juries & bestowed to the deserving Leaders & Enterprises after a through screening of their landmark achievements for their significant accomplishments in their own fields under tough conditions imbibing innovation in their business approach. Clearly India Leadership Conclave & Indian Affairs Business Leadership Awards 2013 are India’s most eagerly awaited & prestigious title in recent times”. This Year’s Nominations has inclusion of some new categories such as Rising Brand Campaign Of The Year 2013, Brand Icon of The Year 2013, Corporate Governance & Sustainability Vision Award 2013 etc to make it much more wider & value-centric said Satya Brahma.
The Companies & Individuals who made it to the top five final categories are
1. Business Leader of The Year
1. Dr. K. Ravindranath,Chairman & Managing Director – Global Hospitals Group. ( Code 01)
2. Rajiv Bajaj,Vice Chairman & MD.Bajaj Capital Ltd. ( Code 02)
3. Nirmal Jain.Managing Director, India Infoline Ltd. ( Code 03)
4. Malvinder Mohan Singh, Chairman, Fortis Healthcare Ltd. ( Code 4)
5. Mr. Joseph Massey, Managing Director & CEO, MCX Stock Exchange Ltd. ( Code 05)
2. Businesswoman of the Year
1. Dr. Jyotsna Suri, Chairperson & Managing Director, Bharat Hotels Limited Enterprise. ( Code 06)
2. Zoya Akhtar, Producer & Director, Indian Cinema. ( Code07)
3. Renuka Ramnath, Founder, Managing Director, Multiples Alternate Asset Management. ( Code 08)
4. Shikha Sharma, CEO & MD, Axis Bank Ltd. ( Code 09)
5. Priya Paul, Chairman. Apeejay Surrendra Park Hotels. ( Code10)
3. India’s Most Valuable 4 Wheeler Company of The Year.
1. Volkswagen Passenger Cars. (Code 11)
2. Toyota Motors Ltd. (Code 12)
3. Renault India Private Limited. (Code 13)
4. Maruti Suzuki India Limited. (Code 14)
5. Fiat Group Automobiles India Pvt. Ltd. ( Code 15)
4. India’s Most Valuable IT Software Company.
1. Datamatics Global Services Limited. (Code 16)
2. Take Solutions Ltd. (Code 17)
3. First source Solutions Limited. (Code 18)
4. 3i Infotech Ltd. (Code 19)
5. ABM Knowledgeware Ltd. (Code 20)
5. Outstanding Contribution to Skincare Innovation Award 2013.
1. Dr. Rashmi Soni Lohiya, Head and consultant dermatologist, Cosmetologist.CEO, Dermatosurgeon, Skinsure Clinic. (Code 21)
2. Dr. Tripti Rathore,Master of Science Dermatology, MBBS,Clinical Director & Lead Dermatologist. ( Code 22)
3. Dr. Uday Preet Sidhu. Consultant Dermatologist & Cosmetologist. (Code 23)
4. Dr Nilayini. Consultant Dermatologist & Cosmetologist, Founder CEO, Blu skin and cosmetology clinic. (Code 24)
5. Dr Shuba Dharmana. Consultant Dermatologist, Hair Transplant Surgeon, Laser Specialist.CEO/Founder Dr.Shuba Skin & Laser Clinic. (Code 25)
6. Emerging Medical Equipment Company of the Year 2013
1. Avon Weighing Systems Limited. ( Code 26)
2. Contech Instruments Ltd. (Code 27)
3. Elder Instrument Pvt Ltd. (Code 28)
4. Preci-Tech Weighing Systems. (Code 29)
5. Mettler-Toledo India Private Limited. (Code 30)
7. CEO of the year.
1. Puneet Chadda, CEO, HSBC Asset Management (India) Pvt Ltd. (Code 31)
2. Jayant Dua. MD & CEO, Birla Sun Life Insurance. (Code 32)
3. Mr. Arun Sawhney. CEO & Managing Director, Ranbaxy Ltd. (Code 33)
4. Mr.Upinder Zutshi. MD & CEO, Infinite Computer Solutions India Ltd. (Code 34)
5. Mr.Ishan Raina. CEO & Managing Director, Out of Home Media (India) Pvt. Ltd. (Code 35)
8. First Generation Entrepreneur of the year
1. Virendra Mhaiskar. Chairman & MD, IRB Infrastructure Developers. (Code 36)
2. Prakash Guha. Managing Director. Zuventus Healthcare Ltd. ( Code 37)
3. Sachin Bansal and Binny Bansal. Flipkart.com. ( Code 38)
4. Sumant Sinha, Chairman & CEO, ReNew Power. ( Code 39)
5. Ram Chandra Agarwal. Founder Chairman,Vishal Retail.( Code 40)
9. Deal Maker of The Year 2013.
1. 1.Copart inc. (Code 41)
2. 2.Flickpart. ( Code 42)
3. 3.Via. (Code 43)
4. 4.Carwale. (Code 44)
5. 5.Yatra. (Code 45)
10. Emerging Company of the Year 2013 (Textiles)
1.Sudar Industries Limited. ( Code 46)
2.Bombay Rayon Fashions Ltd. (Code 47)
3.Gokaldas Exports Limited (GEL). (Code 48)
4.Provogue (India) Limited. (Code 49)
5.Sutlej Textiles and Industries. ( Code 50)
11. India’s Valuable Financial Consultancy & Stock Brokerage Company 2013
1.Angel Broking. (Code 51)
2.Edelweiss Group. ( Code 52)
3.Religare Securities Ltd. ( Code 53)
4.Kotak Securities. ( Code 54)
5.Bonanza Portfolio Ltd. (Code 55)
12. India’s Most Valuable Financial Legal Firm of the Year 2013
1.Link Legal. (Code 56)
2.Khimji Kunverji & Co. (Code 57)
3.DSP Merrill Lynch Ltd. (Code 58)
4.DSK Legal. (Code 59)
5.J.Sagar Associates. (Code 60)
13.India’s Most Admired Beauty Expert (Medical Profession)
1. Dr Rachita Dhurat. Cosmetic Dermatologist & Professor& Head in Dermatology LTM Medical College & LTMG Hospital. ( Code 61)
2. Dr. Rinky Kapoor. Consultant and Head – Department of Cosmetic Dermatology and Lasers – Fortis Hospitals, Mahim. (Code 62)
3. Dr.Jaishree Sharad. Cosmetic Dermatologist &CEO of Skinfiniti Aesthetic Skin and Laser Clinic, Vice President of the highly esteemed Cosmetic Dermatology. (Code 63)
4 .Dr. Rashmi Shetty. Cosmetic Dermatologist & leading expert for Non-Surgical Aesthetic Medicine in India. ( Code 64)
5. Dr Madhuri Agarwal. Cosmetic Dermatologist & Medical Head for West Region- Kaya Skin Clinic. ( Code 65)
14. India’s Most Valuable Company in Healthcare Innovations 2013
1.Wanbury Ltd. (Code 66)
2.Aristo Pharmaceuticals Ltd. (Code 67)
3.Akumentis Healthcare Ltd. (Code 68)
4.Indoco Remedies Ltd. (Code 69)
5.Indchemie Health Specialities Pvt. Ltd. (Code 70)
15.India’s Emerging Healthcare Company of the Year 2013.
1.Wanbury Ltd. (Code 71)
2.Macleods Pharmaceuticals Limited. (Code 72)
3.Blue Cross Laboratories Ltd. (Code 73)
4.Wallace Pharmaceuticals Ltd. (Code 74)
5.Zuventus Healthcare Ltd. (Code 75)
16. Clinical Trials Data Management Company of The Year 2013.
1.Quintiles India Ltd. (Code 76)
2 Clintrac International Private Limited. (Code 77)
3.Karmic Labs Pvt. Ltd. ( Code 78)
4.Semler Research Center. (Code 79)
5.Cytespace Research Private Limited . ( Code 80)
17. India’s Most Valuable Private Bank.
1.Icici Bank Ltd. ( Code 81)
2.Axis Bank Ltd. ( Code 82)
3.Yes Bank Ltd. (Code 83)
4.Standard Chartered Bank. (Code 84)
5.Citi Bank NA. (Code 85)
18.India’s Most Valuable Public Bank.
1.Bank of Baroda. ( Code 86)
2.State Bank of India. (Code 87)
3.IDBI Bank Ltd. (Code 88)
4.Punjab National Bank. (Code 89)
5.Oriental Bank of Commerce. (Code 90)
19. India’s Most Valuable Retail Electronic Company of the year.
1.Reliance Digital Limited. (Code 91)
2.Croma (Infiniti Retail Limited ). (Code 92)
3.NEXT Retail India Ltd. (Code 93)
4.E-Zone ( Future Bazar Ltd). (Code 94)
5.Viveks Ltd. (Code 95)
20.India’s Most Reliable Payment Gateway Company 2013
1.Itz Cash Card Ltd. ( Code 96)
2.E-BIlling Solution Pvt Ltd. (Code 97)
3.Avenues India Pvt Ltd. ( Code 98)
4.DirecPay. ( Code 99)
5.PayU Group. ( Code 100)
21. India’s Most Promising B-School of the Year 2013.
1.Amity University. (Code 101)
2.The Indian School of Business. (Code 102)
3.The Indian Institute of Planning and Management. (Code 103)
4.Welingkar Institute of Management Development & Research. (Code 104)
5.Lal Bahadur Shastri Institute of Management & Technology. (Code 105)
22.India’s Emeging Healthcare Chain 2013.
1.DM Healthcare. (Code 106)
2.Hinduja Healthcare Pvt. Ltd. (Code 107)
3.Radiant Life Care Pvt Limited. (Code 108)
4.Columbia Asia Hospitals. (Code 109)
5.Max Healthcare. (110)
23. India’s Most Promising Telecom Company of the Year 2013.
1.Aircel. ( Code 111)
2.Vodafone. (Code 112)
3.Airtel. (Code 113)
4.Uninor. (Code 114)
5.Reliance. (Code 115)
24. Rising Brand Campaign Of The Year 2013
1.Made In India, A United Initiative. (Code 116)
2.India Brand Equity Foundation. (Code 117)
3.Interbrand ( Mudra Communications). (Code 118)
4.Lowe Lintas & Partner. (Code 119)
5.Campaign India (Haymarket Media India Ltd). (Code 120)
25. Brand Icon of The Year 2013.
1.Kiran Bedi ( Social Reforms). (Code 121)
2.Virat Kohli ( Sports). (Code 122)
3.Katrina Kaif (Cinema). (Code 133)
4.Jaipal Ramesh (Politics). (Code 134)
5.Shailendra Singh (Branding & Communication). (Code 135)
26. Emerging Brand of The Year 2013
1.Chericof Cough Series ( Ranbaxy). (Code 136)
2.Coalgate (Hindustan Lever Ltd.). (Code 137)
3.Coca-Cola ( Coca-Cola India Private Limited. (Code 138)
4.Nokia ( Nokia India Ltd). (Code 139)
5.Ponds. (Hindustan Unilever Limited). (Code 140)
27. India’s Most Valuable Company in Database Management.
1. Oracle India Private Limited. (Code 141)
2. Sybase Software India Pvt Ltd. (Code 142)
3. Datavail Infotech Pvt. Ltd. (Code 143)
4. Dataguru India Pvt Ltd. (Code 144)
5. Clover Infotech Pvt. Ltd. (Code 145)
28. Corporate Governance & Sustainability Vision Award 2013
1.Mindtree Ltd. (Code 146)
2.Marg Ltd. (Code 147)
3.Power Grid Corpn. of India. (Code 148)
4.Hiranandani Constructions Pvt.Ltd. ( Code 149)
5.Aanjaneya Lifecare Ltd. (Code 11)
29. Social Enterprise of The Year 2013
1. Samarthanam Trust for the Disabled . (Code 146)
2. CRY (Child Rights and You) . (Code 147)
3. Trinayani. (Code 148)
4. Save The Children India. ( Code 149)
5. US Charities . (Code 150)
Individual Categories by Juries Verdict & Popular Choice ( No Votings)
1. Transformational Leader of the Decade. Ratan Tata, Chairman Emeritus of the Tata Group
2. Millennium Business Leader of the Decade, Mr. Mukesh Dhirubhai Ambani, CMD, Reliance Industries Ltd.
3. Global Indian of The Year 2013 (Healthcare). Dr Mukesh Batra, Chairman, Dr Batra's
4. Fashion Icon of The Year 2013 - Manish Malhotra, Fashion Designer.
5. Indian Healthcare Visionary of the Decade - Dr Mukesh Hariawala, Cardiac Surgeon & Healthcare Economist.
6. Actress of the Decade – Ms.Priyanka Chopra
7. Lifetime Achievement Award : Prof. Dr. Nandkishore Shamrao Laud, Orthopaedic Surgeon, Chairperson, Laud Clinic.
1. Nominations for 4th Annual India Leadership Conclave & Business Leadership Awards 2013 voting starts on 1st April 2013 to 17th June 2013. www.indialeadershipconclave.net/2013
2. All Five Finalists are required to furnish details from time to time whenever the documents are required based on changing market conditions.
3. There are Five tier system of votings.
4. Vote By SMS : One can vote to any category by simply putting the Codes assigned to each Nominee. Xxxx to official Number 91 9036065456
5. Vote by Email . One can vote to categories such as Code Number Mentioned in the Website.For Example, 1234 to email@example.com
6. The Organizers will conduct physical Interviews from the respective Category’s Target audience & the general public to count votes. This has been practice since all editions.
7. Online Votings in the Wewbsite at www.indialeadershipconclave.net/2013
8. Final Verdict by the Juries & Board Members.
9. The decision of the Juries is final & bindings to all categories.
10. Final Results will be announced on 21st June, Friday, Hotel Lalit, Near Airport, Mumbai on the Award Night.
11. Special Categories Listed in Nomination Form need no Votings.
12. Only One vote by one person will be counted in both SMS as well as Email. Duplicate/Repeat votings will be rejected.
13. No need to Wite (Codes) while sending SMS Votings. Example Type 1234 Send To 91 9036065456
14. Standard Charges apply from any network, No additional charges as these are not commercial in nature.
15. 40 % Weightage will be given to Winner generated fron Public Votings via SMS & Emails. The Remaining 60 % will be on the Merits & Credentials as stipulated in Nomination Form.
Websites For Three Consecutive Conclaves can be seen at www.ilcbusinessleaders.com www.indialeadershipconclave.com www.indialeadershipconclave.net . Official Website for 2013 Nominations is www.indialeadershipconclave.net/2013
For Registrations, Please Contact :
India Leadership Conclave Secretariat
Unit No. 53, 2nd Floor,
Aditya Indistrial Estate,
Devrukhkarwadi, Chincholi Bunder,
Malad (W), Mumbai – 400 064
Phone: + 91 22 4248 1240 / 4248 1234 / 4248 1235
Aanjaneya Lifecare Set To Join Hands With Japanese Pharma Major For Breakthrough Anti-Malarial Molecule for Collaborative Research & Co-Marketing
Financial Muscle To Be Robust With Foreign Currency Convertible Bonds – Dr Kannan Vishwanath, MD, Aanjaneya Lifecare Ltd.
Mumbai, Maharashtra, India. 6th March 2013. Around 80 per cent of new drugs are brought to market by the big global majors, even though only 35 per cent of these have been developed by them from the earliest stage. Smaller companies engaged in research often find going the full course up to the market beyond their means and end up out-licensing their NCEs to the big pharmas. India, the country most affected by malaria in the South East Asian region, is projected to see a decrease of 50-75 per cent in malaria case incidence by 2015, a report by the World Health Organization said. The WHO's World Malaria Report 2012 said a concerted effort by endemic countries, donors and global malaria partners during the past decade has led to strengthened malaria control around the world. It however warned that a significant slowdown in global funding. Mumbai-based Aanjaneya Lifecare Limited Aanjaneya Lifecare having a significant presence in this segment, is the world’s third-largest manufacturer of quinine salts and the second-largest in India. Only nine companies globally manufacture quinine salts. Aanjaneya is only the second company to receive WHO prequalification for its anti-malarial APIs and formulations, is inching closer to a breakthrough research in the form of a Molecule in Research Partnership for collaborative marketing with a leading Japanese Pharma Major. If sources are tobe believed than the that the drug which has a 10 tears of Research could cure all strains of malaria with a single oral dose and also block transmission of the deadly parasite from person to person. It may be noted here that Of the four major types of malarial parasites, it is plasmodium falciparum, carried by the female anopheles mosquito, which causes about 90 per cent of the malaria deaths. Synriam, is intended to combat falciparum malaria, has two major advantages over other drugs like chloroquine. Its dosage regimen is just one tablet for three days, while other drugs have to be taken twice or four times a day for three or more days. Interestingly Ranbaxy worked for a revolutionary Drug with Research going for 15-years of drug discovery. Cipla is also a leading player in this market. With this partnership, Aanjaneya Lifecare which is a leading supplier to most of the Indian Companies will look forward for a better deal in doing business in india. With a significant market presence with manufacturing and marketing capabilities in APIs (Active Pharmaceutical Ingredients) with focus on anti-malarial, and finished dosage forms (FDFs) , Aanjaneya Lifecare could fetch a bigger fortune as anti-malarial drugs market in india is growing at ~25% & Anti-malarial market size in India is estimated at Rs600 crore. The Company is yet to enter into domestic branded formulation market, though it has plans to start the fiercely competitive Indian market operation by early 2013.
Dr Kannan Vishwanath, Vice Chairman & Managing Director of Aanjaneya Lifecare Ltd in an exclusive interview to Satya Brahma, Editor-In-Chief of Pharmaleaders Group spoke on wide gamut of business & expansion plans including the decline of share prices due to tough market conditions. Aanjaneya Lifecare Ltd stock was trading at Rs.299.80, down by Rs.15.75 or 4.99%. The stock hit an intraday high of Rs.299.80 and low of Rs.299.80.The total traded quantity was 213 compared to 2 week average of 21517.
1. According to data available with the stock exchanges, shares of Core Projects tumbled 62 per cent and was the biggest loser on the entire BSE, while scrips of Aanjaneya Lifecare, Sudar Inds, Flexituff, ABG Shipyard, Welcorp and Gemini Comm crashed by 20 per cent each. Any Specific Reasons?
Answer: If you look at the overall scenario, you will get a clear indication that some of the biggest Midcaps have been losing grounds primarily because of the toughest market conditions & Aanjaneya Lifecare is not an exception. We are definitely disturbed as trading in stock exchange has become challenging but this is a temporary phase, we have a strong growth plans & we are gearing for top gear with our ambitious plans. The Board of Directors of Aanjaneya Lifecare Ltd at its meeting held on March 05, 2013, have decided that the date of opening of issuance of FCCB up to USD 75 million is on March 12, 2013. Of late, we find a huge fluctuation in the market prices of our scrip and it is disturbing for us. In order to achieve the growth plans of the Company, we are in dialogue with our International Bankers for raising resources for the expansion through FCCB. The international investors are cautious due to wide fluctuation in the market price of our scrip."
2. The S&P BSE mid-cap index fell by 1.20 per cent and S&P BSE small-cap index lost 1.36 per cent.What are the reasons for this decline?
Answer: As explained earlier, this is a volatile market conditions in all S&P BSE mid-cap index. You can’t expect healthier trading every day. Please look at our performances in our Annual Report, we have outpaced industry standards. While it will take sometimes to gain the momentum, we are confident of good numbers. No need for Investors to be panic. Investors can be assured of their returns as they have been getting earlier. Global Market volatility is also one of the factor. The midcap universe came under pressure largely on account of concerns about their earnings as some of them have reported Q3 numbers, which came below market expectations.
3. While your Net profit declined by 13.9 per cent to Rs.10.45 crore from Rs.12.14 crore, though its net sales increased sharply by 35.6 per cent to Rs.145.86 crore from Rs.107.58 crore. What is your expectations from the next quarter?.
Answer: Please look at our announcement which is much healthier. With new capacities to be added in next 6 to 9 months the company will be expanding operations in emerging markets of South East Asia, Africa & South & Central America and its domestic operation in branded generics segment. The Company has reported a growth in the total Sales to the extent of 35.58% at Rs 1458.64 million during the third quarter ended 31st December 2012 compared to Rs 1075.78 million during the same period last year. The net profits for Q3 amounted to Rs 104.53 million as against Rs 93.37 million for the previous quarter ended 30th September 2012 and Rs 121.42 million for the corresponding period of previous year ended 31st December 2011. We will have a bigger chunk in next quarter though I can’t specify the numbers, it will definitely be bigger.
4. Aanjaneya Lifecare has been a dark horse in Pharma Scrips since its IPO in 2009 as it has been consistently performing. Why there is a sudden fall?
Answer: As I have mentioned in my earlier note, we have a sound financials with a robust processs mechanism. Our Corporate Governance is our biggest strength. We have no huge debtors like other Pharma Companies. We have recorded good performance in a difficult period and the future is bright. We are seeing a promising period for the company one in which we could achieve our goals set towards customer satisfaction, quality standards and of course shareholder value. We will keep the growth momentum focused & visible. Coming Days will spell out our success in overseas markets.
5. Do you have any overseas creditors as speculations are that you may have pressure to pay off?.
Answer : There are no such overseas creditors except our domestic vendors who import machineries from abroad.
6. What are your expectations on the normalcy to prevail & bring back Investors confidence?.
Answer: As you will be aware that Aanjaneya Lifecare Limited has got approval to issue Foreign Currency Convertible Bonds to eligible foreign investors amounting Rs.405 crore. We are working on the modalities & soon some positive news will come as I cant divulge more details at this point of time.
7. What is your take on Union Budget 2013 & how Pharma sector has been represented?
Answer. The Entire Indian Inc has welcomed Finance Minister’s Budget on a positive note & Aanjaneya can say that Chidambaram had a tough task to meet. FM has gone by reforms & Prudence & not by Populism. ThoughAanjaneya would have been happier if FM would have announced some landmark decisions. However, it has a ambitious direction. An industry that has grown from being fully dependent on foreign companies a few decades ago to being an indigenous entrepreneur-driven industry with over Rs 64,000-crore market today, an industry that has over 10,000 small and medium enterprises and about 300 large enterprises all over India, an industry that provides over 64,000 safe and efficacious medicines at affordable prices, an industry that provides employment to over 40 lakh people, an industry that has contributed significantly in improving the standard of life and life expectancy, bringing down the death rate and infant mortality rates etc. of our people, an industry that our Government is very proud to showcase to the world as ‘Pharmacy of the World’, an industry that has earned the respect, admiration and dependence of all countries of the world for providing safe, efficacious, affordable quality medicines – has been completely ignored in the Budget as pointed out by Secretary General of Indian Drug Manufacturers Association, Mr Daara Patel.. The pharmaceutical industry has been facing problems of huge CENVAT accumulation due to the inverted duty structure resulting in blockage of working capital and affecting competitiveness in international market and this needed to be addressed urgently. Considering the long-term benefits of R&D to the economy at large, all excisable goods used for R&D purposes should have been exempted from excise duty as also import of all capital goods to boost our R&D activities to produce and provide our people with the latest more therapeutic medicines, exemption of physician samples from central excise duty, and reduction of customs duty on all life-saving drugs, etc.The Indian pharma industry has always responded to the urgent calls of pharma Government, both in Centre and in States, in times of disaster and natural calamities by providing free medicines anywhere in India, without minding the production costs and expenses involved in reaching the medicines to those affected victims. It is sad that despite our repeated requests and representations, the Government continues to tax these voluntary free medicines by imposing excise duty and sales tax on them. It has been a very lopsided budget, in that investment allowance @ 15 per cent has been allowed to manufacturing companies that invest more than Rs 100 crores in plant and machinery in the next two years. Most of the manufacturing industries in India are small scale driven, with even our Prime Minister calling them ‘engines of growth’. How many companies can invest ‘more than Rs 100 crores’? It effectively blocks the lakhs of MSME units in India, not to mention over 10,000 units in the pharma industry from availing of this benefit. The 12th Five Year Plan in the report on MSME sector states that it is the “major base of manufacturing sector in India, with its contribution of over 45 per cent in the overall industrial output and calls for “substantial enhancement of plan allocation for the sector during the 12th Plan to address major bottlenecks facing the sector.”
No wonder many in the Indian pharma industry now feel that it is a futile exercise to spend time and effort providing our pre-Budget proposals for drafting the Union Budget year-after-year, as the Finance Ministry has been ignoring the industry time and again in the last few budgets.
8. Experts see Markets may see consolidation, Q3 results to set tone& Stock markets are expected to see some consolidation this week amid traders expected to closely track the next batch of quarterly results. What is your take on this?.
Answer: Yes very true, the Market is going to be robust & Q3 results will be better for most of the Pharma Companies who are performing well. As far as Aanjaneya Lifecare is concerned, We are sure to cross the good numbers.
9. Market is abuzz with speculation that Aanjaneya Lifecare is inching closer to a Japanese Drug Maker for a Collaborative Breakthrough in Anti-Malaria Segments to produce & Market Drugs in your Pune Facilty. Can you explain more on this?.
Answer: I have been getting this news from the market & from media reports ever since a delegation of pharmaceutical firms from Japan's Toyama prefecture indicated few days back while they were in india that Japanese companies were keen to collaborate with Indian pharma companies in trade and technology development. Toyama, which is recognized as the cluster city of pharmaceutical industry in Japan, has around 100 companies. Japanese Delegation had said that they were looking for long term partnerships with Indian companies. There is immense scope of exporting Japanese products to Indian market and similarly Indian products can be traded in the Japanese market,". And I think, I think it is too early to speculate on meetings with Japanese Companies.
10. The Deal is widely perceived that you may be the First one to tie up with a Japanese Firm to give you market access to Regulated Market. Is this True??
I can’t speculate on media reports. I am neither denying nor announcing anything. It is true that Aanjaneya Lifecare has plans to enter into the regulated markets, but we can’t comment on any developments as there is nothing to share as of now.
Skincare Treatment Will Soon Become Affordable To Rising Indian Middle-Class – Dr Nilayini of Blu Skin & Cosmetology
With the increasing stress levels, mirrored with an escalation in pollution, both outdoors and indoors, the incidence of skin ailments is on the increase! And most of these conditions can have an effect of incapacitation on the person enduring the skin problem
India. Maharashtra, Mumbai, Saturday, 9th Feb 2013 . With the increasing focus on enhancing beauty care coupled with latest innovations in skincare treatment, the Indian Wellness Market has grown by leaps & bounds. It is no secret that a quite a sizeable chunk of urban as well as Semi Urban market in India is witnessing the emergence of “New Look Woman’ as well as ‘Extra & Enhanced Beauty Care for Men’ as they set to make their presence in their professional life to look different & add a persona. While the traditional concept of treatment is still in practice, the mood of the nation seems certainly signaling a metamorphosis. The need to add extra impression seems to redefine the whole concept of looking good. The wider treatment such as Botox,Fillers,Chemical Peels,Skin Polish,Microneedling,Acne Scars,Acne,Hydrafacial,Laser Hair Removal,Skin Tightening,Wrinkles & Lines,Skin Brightening,Skin Hydration,Microdermabrasion,RF Refirme Treatment,Dermaroller Therapy,Mesotherapy,Pumpkin Peel,Vit C Peel,Body Clinic,Laser Hair Removal,Tan Removal,Skin Polish,Enzyme Polish,Scar Removal,Decollete / Neck,Hands Feet,Elbows & Knees,Stretch Marks,Warts/Skin Tags,Mole Removal,Lipo-Dissolve,Platelet Rich Plasma Therapy,Scar & Stretch Marks Treatment,Hair Clinic,Dandruff,Hair Loss,Stem Cell Therapy,Psoriasis,Hair Transplantation,Super Laser Hair Removal has dominated the beauty care market. More & More Dermatologists are increasingly feeling their space in cosmetic care as it gives great earnings as well as newer experimentation. Of late we have witnessed more & more Doctors want to pursue Derma, Cosmetic & Hair Plant course post their MBBS. While many prefer overseas institutions to fulfill their training needs, Indian institutions remain more cost effective to their basic choice. Today’s Dermatologists & Cosmetologists are no more confined to their basic skincare needs, but has expanded into latest high-tech labs for beauty care treatment. It seems sometimes that it has become a necessity than luxury though the subject still needs a wider debate as the cost component is a major deterrent feels Satya Brahma, Editor-In-Chief of Pharmaleaders Magazine. India is a unique Market quite compared to the western market which is dominated by lifestyle needs to glow up their skin, In India, though price is a major factor, the skincare market is certainly growing very big & given the present scenario where looks dominate merit (mostly), the role of Dermatologists & Cosmetologists are increasingly becoming challenging & ever demanding as The skin care market is valued at Rs 400 crore for 2012 and is growing at a CAGR of 15 per cent, Satya added.
To understand what drives the mindset of the people’s perception, Pharmaleaders spoke to Dr Nilayini, the founder of South India’s one of the most sophisticated state of the art centre, Blu Skin & Cosmetology which also has a Spa. In an exclusive Interview to Satya Brahma, Editor-In-Chief of Pharmaleaders, Dr Nilayini spoke on wide ranging topics of the past, present & gradual evolution of the skincare industry & its treatment process. Dr Nilayini,Founder,M.B.B.S,DD (Dermatology)(UK), is the prestigious member of American Society of Aesthetic and Cosmetic Physicians. Dr. Nilayini has been accredited nationally and internationally in various advanced cosmetic procedures like Fillers and Botox. She started Blu Skin & Cosmetology – the first of its kind, in the high profile area of Hyderabad ie Jubilee Hills, an abode to many niche clients in and around Hyderabad and from other cities & countries. Blu Skin & Cosmetology is the pioneer among the Beauty Medical Spas in Hyderabad, in terms of facilities , infrastructure & services offered. Blu Skin & Cosmetology was inaugurated by the legendary actor Akkineni Nagarjuna. The aesthetic caliber that Dr Nilayini possesses is far beyond questioning , and with the patient success reviews she gets about Blu Skin & Cosmetology, it is beyond doubt that she is the prime & hard force in the reckoning, especially in the field of aesthetic cosmetology.
Excerpts from the Interview.
PL : Is skincare treatment a Luxury or a Necessity?
The common perception that it is a luxury, which probably was true to a major extent! However, with the increasing stress levels, mirrored with an escalation in pollution, both outdoors and indoors, the incidence of skin ailments is on the increase! And most of these conditions can have an effect of incapacitation on the person enduring the skin problem. The good news is that a majority of these skin conditions can be cured with medications and evidence-based interventions, thereby not only reducing and limiting the morbid situations but also increasing the quality of life!
So, what used to be a luxury, is now a necessity in not only persons whose occupation demands a flawless skin (personnel belonging to hospitality industry, theatre and movie industry, aviation industry personnel and receptionists) but also in persons who are enduring various skin ailments.
PL. The Market for Skincare or Beauty care is increasing. Do you feel the Price war with your competitor Skin Specialists?
Skin care is wrongly perceived as being “expensive” and the same care will be made available at a lesser price elsewhere! The truth of the matter is, like in all professions, providing a high standard of care and therapy needs investment in equipment that is of international standards, and more importantly ratified authorities such a USFDA. Centers that provide such quality of care are very few in our country, so the issue of ‘price war’ is of lesser importance when compared to providing safe and state of art care!
PL. Is Hyderabad a Perfect Market for a Celebrity Cosmetologist?
Hyderabad is the fourth most populous city in India and also boosts a higher sex ratio compared to the national average! The health awareness is on the rise, thanks to the blooming IT centers and also to the fact that Hyderabad hosts only the umpteen numbers of national and multinational companies, in addition to the telugu-film industry, which produces the largest number of motion-pictures in India! Therefore, Hyderabad has the potential to be a ‘perfect market’ for celebrity cosmetologists!
PL : When did you Conceive Blu Skin & Cosmetology, Was there a need?
‘Blu’ was conceived when I was a medical student. After qualifying as a doctor, I felt the need to have an overview of all the various disciplines, therefore, after gaining adequate experience in the major medical fields; I achieved my immediate objective of starting a skin and cosmetology clinic in 2009. Having made a niche as a preeminent center, my secondary objective is to evolve Blu into the best Skin and Cosmetology center in the country!
PL. Has Indian Middle Class Woman come of ages & Ready to spend extra Pound to look Beauty?
Our present ‘middle class’ is expected to reach or cross 40% (or > 500 million) of our vast population. With India witnessing one of the fastest growth in economies, even the purchasing power parity is expected to increase from 4.7% to 6.1% of the world share by 2015. Given these facts, the average Indian middle class woman is surely on her way to state of increased awareness of all-round and has the potential to spend the extra rupee on looking ‘good’, thereby increasing their self-esteem!
PL. What is your take on Laser Hair Removal VS Bikini Waxing?
LHR is a medical procedure where as bikini waxing is not. LHR is carried out by a certified professional. LHR is long lasting results, safer and less painful than bikini waxing. Apart from all this it greatly cost effective. Whereas bikini waxing poses a lot of health hazards, like infections and side effects.
PL. Do you have plans to spread your Clinic all India, If so when & How?
As I have already mentioned, having achieved the objective of starting Blu, the second objective is to evolve and progress to being the best in the business! Once I achieve this secondary objective (which I believe that we are on our way), we then will look at the third objective of establishing more centers in other cities across India.
PL. How can you see you are offering a different treatment than others?
Our treatments are more personal and specific. We do not believe in quantity we believe in Evidence & quality based medicine moreover the safety procedures are adapted by us is one of its kind.
PL. What is the most common myth about acne?
That it is “curable”! Acne, though a common physiological consequence, can be controlled to a significant extent, by a comprehensive approach. This involves a detailed assessment comprising of going into the life-style, diet, family history, medication history, allergies and associated hormonal imbalances, if any. In most of the cases, acne can be controlled and cured, though not in all the cases.
PL. When did you first know you wanted to create your own line of beauty Clinic?
Like I said earlier, I always felt that I can do more here because the idea of making someone look more beautiful was very exciting to me. This realization happened during my student years.
PL. How did you garner such a celebrity following?
By inflexible adherence to quality of care that we impart and provide to all our clients. In fact, all our interventions are under the aegis of evidence-based practices, most of which have evolved after vigorous clinical trials.
PL. Can you share some beauty tips that every woman should know?
I believe every person born beautiful! The only way to maintain this God’s given endowment is to follow a healthy lifestyle, which comprises consuming proper diet and imbibing adequate non-alcoholic and non-caffeine containing fluids, adequate physical activity and regular exercise, and getting adequate sleep. Some persons have skin types which are more prone to rashes, pigmentation and eruptions, which can be prevented or controlled to a significant extent by avoid direct exposure to sun and using sun-screens with an SPF of 25 or more.
PL. What is the secret to great looking skin?
In addition to the above, there are other ways are to avoid smoking and highly polluted environments. Avoid the day-today stresses from becoming severe by taking up meditation or an active hobby!
PL. What ingredients do you recommend that make a difference? What is the main ingredient to look for other than benzyl peroxide? What difference do over the counter creams and lotions make to common acne?
I recommend Retinoic acid 0.50%, OTC may work in mild cases but for moderate to severe with some underlying causes it is may actually worsen therefore it is always advised to consult a doctor
Would you ever advise hormone control or the pill to younger women? What should a dermatologist do before prescribing treatment?
After the through check up of the patient ruling out any possible risk factors and after clinical and laboratory investigations and also the opinion taken from the specialty doctor of the client Hormone control pills can be prescribed to younger woman. Before prescribing a derm has to take safety procedures
PL. Celebrities seem to be perfect. The right figure, skin, eyes, make up, hair etc and with no amount of effort do we get to own the same. Why? The reason is lack of dedication and demand. Celebrities can't afford to look bad, thus they are dedicated to their regime but there is also the concept of celebrity beauty secrets. Each one has one secret to their perfect beauty, which makes them different from the common mass. What is your take on this?
The way the celebrities take care of their body and skin is entirely different, which a common man cannot maintain in his day-to-day activity, most of it is also a combination of genes and compliance. What they have achieved is only due to a lot of dedication and practice. Having said this, there is an individual decision and thorough effort that goes into differentiating a celebrity from a common man.
Looking perfect is a part of their profession and it’s a necessity for them to be conscious and careful about what their appearance is and this differentiates them from the common people, in case of common people , it’s their choice, it’s the way how the individual wants.
PL. How will you sum up about yourself as a Doctor & as an Individual?
As a medical doctor I follow the dictum of “primun non nocere” i.e., first of all, do no further harm! My medical training puts be in a position to completely assess the person’s medical status, with a view of tolerance or intolerance of the planned therapy, and the possible outcome. Only after a thorough assessment, that we commence our interventions. As an individual, it is an immense satisfaction to note that all my clients have a postitve outcome and I have contributed in a way to their happiness!
PL. Do you feel Slimming Tablets can make a Difference in reducing Extra Weight?
There are established guidelines for medication therapy in weight management and when administered under controlled conditions, they achieve the objective of weight reduction. Therefore, the slimming pills have a definite role, if the person falls in this category. In some cases, they have to be taken over a prolonged periods of time.
PL. What are your views on Breast Implants, How Big the market is?
Breast implants is a personal decision that is entirely on the patients call. If it changes her life to a significant extent, in her perception, then so be it! The very fact that the demand for breast augmentation is on the increase in India confirms my point.
PL. What are the complications you have faced while starting your career?
It was a big challenge – as I was the first to start on my own and at a stage where my experience in the economics involved was in its infancy. In addition, Hyderabad market was new to this type of care. However, my learning curve was not a prolonged one, and very soon I got the penchant to assess and impart therapy and also manage the business angle of running Blu!
PL. Would you like to be called as a Millionaire Skincare Specialist?
We stile to impart evidence-based care to all our clients and aim to make a positive-change in their lives! Therefore, I would rather like to known as a skincare specialist who made a difference to a million lives.